Green bio specialist company Genolution announced on the 30th that it will participate in the diagnostics and testing exhibition 'ADLM 2025 (Association for Diagnostics & Laboratory Medicine, formerly AACC)' held in Chicago, USA from July 27th to 31st and introduce a nucleic acid extraction solution for liquid biopsy.
At this exhibition, Genolution will showcase its product lineup applicable to various body fluid-based diagnostic studies, focusing on the NX-Duo and NX-Jr, automated nucleic acid extraction devices optimized for liquid biopsy. These devices offer high-purity cfDNA (circulating free DNA) and exosome-based RNA and protein extraction capabilities, and are attracting attention as research solutions for the development of next-generation diagnostic technologies.
The NX-Duo is a device capable of reliably extracting high-quality cfDNA from a variety of samples, including plasma, urine, and body fluids. It can be used for NGS (next-generation sequencing) and PCR-based precision diagnostics. It is expected to be utilized in various liquid biopsy fields, including early cancer diagnosis, disease monitoring, and prognosis assessment.
NX-Jr is designed to facilitate the extraction of miRNA and proteins from exosomes within approximately 30 minutes. Based on its high reproducibility and processing efficiency, it is expanding its applicability in exosome-based biomarker research and clinical diagnostics.
Genolution will operate its own booth at ADLM 2025, exploring collaboration opportunities with experts from global research institutes, hospitals, and pharmaceutical companies through live equipment demonstrations and one-on-one technical consultations. The company will also unveil an integrated diagnostic platform, including dedicated cfDNA and exosome extraction kits.
A Genolution representative stated, “Liquid biopsy is attracting attention as a next-generation diagnostic technology because it is non-invasive compared to conventional tissue biopsies and allows for repeated testing and precise diagnosis,” adding, “Our solution can be utilized as a foundational technology that provides researchers with both accuracy and efficiency.”
- See more related articles
You must be logged in to post a comment.